GSK surrenders HSV vaccine hopes after phase 2 fail, ceding race to Moderna, BioNTech 0 11.09.2024 11:25 Fiercebiotech.com GSK surrenders HSV vaccine hopes after phase 2 fail, ceding race to Moderna, BioNTech jwaldron Wed, 09/11/2024 - 04:25
